Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor β2 promoter in breast cancer cells

Oncogene

Volumn 19, Issue 12, 2000, Pages 1556-1563

  Sirchia, Silvia M ^a   Ferguson, Anne T ^b,d   Sironi, Elena ^a   Subramanyan, Smitha ^b   Orlandi, Rosaria ^c   Sukumar, Saraswati ^b   Sacchi, Nicoletta ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Pediatric Oncology Unit   (Italy)

^d Calydon Inc   (United States)

Author keywords

Breast cancer; Chromatin remodeling; DNA methylation; Retinoic acid receptor (RAR)

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; RETINOIC ACID; RETINOIC ACID RECEPTOR; TRICHOSTATIN A;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CHROMATIN; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0034673671     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203456     Document Type: Article

References (46)

1. Baust C, Redpath L and Schwarz E. (1996). Int. J. Cancer, 67, 409-416.
2. Bhattacharyya N, Dey A, Minucci S, Zimmer A, John S, Hager G and Ozato K. (1997). Mol. Cell Biol., 17, 6481-6490.
3. Bird A. (1986). Nature, 321, 209-213.
4. Bovenzi V, Le NLO, Cote' S, Sinnet D, Momparler LF and Momparler RI. (1999). Anticancer Drugs, 10, 471-476.
5. Cameron EE, Bachman KE, Myohanen S, Herman JG and Baylin SB. (1999). Nature Genet., 21, 103-107.
6. Chambon P. (1996). FASEB J., 10, 940-954.
7. Chiba H, Clifford J, Metzger D and Chambon P. (1997). Mol. Cell Biol., 17, 3013-3020.
8. Cote' S and Momparler RL. (1997). Anticancer Drugs, 8, 56-61.
9. De The' H, del Mar Vivanco-Ruiz M, Tiollais P, Stunnenberg HG and Dejan A. (1990). Nature, 343, 177-180.
10. Eden S, Hashimshony T, Keshet I, Cedar H and Torne AW. (1998). Nature, 394, 842.
11. Ferguson AT, Lapidus RG and Davidson NE. (1998). Oncogene, 17, 577-583.
12. Folkers GE, van der Burg B and van der Saag PT. (1998). J. Biol. Chem., 273, 32200-32212.
13. Formantici C, Orlandi R, Ronchini C, Pilotti S, Ranzani GN, Colnaghi MI and Menard S. (1999). J. Pathol., 187, 424-427.
14. Grignani F, Dematteis S, Nervi C, Tomassoni L, Gelmetti V, Ciocc M, Fanelli M, Ruthardt M, et al. (1998). Nature, 391, 815-818.
15. Gudas LJ, Sporn MB and Roberts AB. (1994). In: The Retinoids. Biology, Chemistry and Medicine. Raven Press: New York, pp. 443-520.
16. Guidez F, Ivins S, Zhu J, Soderstrom M, Waxman S and Zelent A. (1998). Blood, 91, 2634-2637.
17. He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A and Pandolfi PP. (1998). Nature Genet., 18, 126-135.
18. Hebbes TR, Clayton AL, Thorne AW and Crane-Robinson C. (1994). EMBO J., 13, 1823-1830.
19. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB. (1996). Proc. Natl. Acad. Sci. USA, 93, 9821-9826.
20. Jones PL and Wolffe AP. (1999). Semin. Cancer Biol., 9, 339-347.
21. Keshet I, Lieman-Hurwitz J and Cedar H. (1986). Cell, 44, 535-543.
22. Li X-S, Shao Z-M, Sheikh MS, Eiseman JL, Sentz D, Jetten AM, Chen J-C, Dawson ML, Aisner S, Rishi AK, Gutierrez P, Schnapper L and Fontana JA. (1995). J. Cell Physiol., 165, 449-458.
23. Lin RJ, Nagy I, Inoue S, Shao W, Miller Jr WH and Evans RM. (1998). Nature, 391, 811-814.
24. Liu Y, Lee M-O, Wang H-G, Li Y, Hashimoto Y, Klaus M, Reed JC and Zhang X-K. (1997). Mol. Cell Biol., 16, 1138-1149.
25. Minucci S, Horn V, Bhattacharyya N, Russanova V, Ogryzko VV, Gabriele L, Howard BH and Ozato K. (1997). Proc. Natl. Acad. Sci. USA, 94, 11295-11300.
26. Minna JD and Mangeldorf DJ. (1997). J. Natl. Cancer Inst., 89, 602-604.
27. Minucci S and Pelicci P. (1999). Semin. Cell Dev. Biol., 2, 215-225.
28. Ng H-H and Bird A. (1999). Curr. Opin. Genet. Dev., 9, 158-163.
29. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN and Bird A. (1998). Nature, 393, 386-389.
30. Razin A. (1998). EMBO J., 17, 4905-4908.
31. Roman SD, Clarke CL, Hall RE, Alexander IE and Sutherland RL. (1992). Cancer Res., 52, 2236-2242.
32. Seewaldt VI, Johnson BS, Parker MB, Collins SJ and Swisshelm K. (1995). Cell Growth Differ., 6, 1077-1088.
33. Shao Z-M, Sheikh MS, Chen JC, Kute T, Aisner S, Sehnaper L and Fontana JA. (1994). Int. J. Oncol., 4, 849-853.
34. Shang Y, Baumrucker CR and Green MH. (1999). J. Biol. Chem., 274, 18005-18010.
35. Shen S, Kruyt FA, den Hertog J, van der Saag FT and Kruijer W. (1991). DNA Seq., 2, 111-119.
36. Smith MA, Parkinson Dr, Cheson BD and Friedman MA. (1992). J. Clin. Oncol., 10, 839-864.
37. Swisshelm K, Ryan K, Lee X, Tsou HC, Peacoque M and Sager R. (1994). Cell Growth Differ., 5, 133-141.
38. Toulouse A, Morin J, Pelletier M and Bradley WEC.(1997). BBA, 1309, 1-4.
39. Tsou HC, Yao YJ, Xie XX, Ping XL and Peacocke M. (1998). Exp. Cell Res., 245, 221-227.
40. Valcarel R, Holz H, Garcia Jimenez C, Barettino D and Stunnenberg HG. (1994). Genes Dev., 8, 3068-3079.
41. Van der Leede BJ, Folkers GE, Kruyt FA and van der Saag PT. (1992). Biochem. Biophys. Res. Commun., 188, 695-702.
42. Wade PA, Jones PL, Vermaak D, Veenstra GJ, Imhof A, Sera T, Tse C, Ge H, Shi YB, Hansen JC and Wolfee AP. (1998). Cold Spring Harb. Symp. Quant. Biol., 63, 435-445.
43. Warrell Jr, RP, He LZ, Richon V, Callega E and Pandolfi PP. (1998). J. Natl. Cancer Inst., 90, 1621-1625.
44. Widschwendtner M, Berger J, Daxenbichler G, Muller-Holzner E, Widschwendtner A, Mayr A, Marth C and Zeimet AG. (1997). Cancer Res., 17, 4158-4161.
45. Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukumanji F, Hortobagy G, Lippman SM, Dhingra K and Lotan R. (1997). Cancer Res., 57, 4992-4996.
46. Yoshida M, Horinouchi S and Beppu T. (1995). Bioessays, 17, 423-430.